JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

The Infiltrative Margins in Glioblastoma: Important Is What Has Been Left behind

  • 0Department of Neurosurgery, FAU University Hospital, Friedrich-Alexander-University, Erlangen-Nuremberg, Germany.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research +

|

August 20, 2024

|

August 20, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Aggressively resecting newly diagnosed glioblastoma beyond visible tumor borders may improve outcomes. This surgical approach impacts other prognostic factors, guiding treatment decisions and clinical trials.

Area Of Science

  • Neurosurgery
  • Oncology
  • Clinical Research

Background

  • Supramaximal resection is an emerging strategy for newly diagnosed glioblastoma.
  • Understanding the impact of aggressive resection on clinical predictors is crucial.

Purpose Of The Study

  • To investigate the interactive effects of supramaximal resection on glioblastoma patient outcomes.
  • To provide evidence supporting surgical decision-making and clinical trial stratification.

Main Methods

  • Analysis of clinical data from glioblastoma patients undergoing supramaximal resection.
  • Evaluation of the interplay between extent of resection and other prognostic factors.

Main Results

  • Evidence suggests supramaximal resection influences other predictors of outcome.
  • The extent of resection is a critical factor in glioblastoma treatment.

Conclusions

  • Supramaximal resection is a key consideration for newly diagnosed glioblastoma.
  • Clinical trials should stratify patients based on the extent of surgical resection.